T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure
- PMID: 8932764
- DOI: 10.1006/expr.1996.0100
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure
Abstract
Patients suffering from American cutaneous leishmaniasis were studied before therapy (active lesion) and at the end of therapy (cured patients). Assays of lymphocyte proliferative responses of peripheral blood mononuclear cells induced in vitro by Leishmania braziliensis promastigote antigens (Lb) or by three proteins (A-2/P-2, P-4, and P-8) derived from Leishmania pifanoi amastigotes were performed. Antigen-stimulated cells were harvested for CD4 and CD8 phenotype analysis and the levels of gamma interferon (IFN-gamma), interleukin 2 (IL-2) and interleukin 4 (IL-4) produced were also determined. Results show two different patterns of Lb-induced T cell responses: (a) predominance of responding CD4+ cells and mixed type 1 and type 2 cytokine production (IFN-gamma, IL-2, and IL-4) during the active disease, (b) similar proportions of responding CD4+ and CD8+ cells and type 1 cytokine production (presence of IFN-gamma and IL-2 and very low IL-4) at the end of therapy (healed lesions). Thus, this last pattern is probably associated with a beneficial T cell response. The A-2/P-2 amastigote cysteine proteinase provided only marginal (s.i. approximately or = 2.5) T cell stimulation in 25% of patients studied; in contrast, the L. pifanoi P-4 and P-8 amastigote antigens induced significant stimulation (s.i. approximately or = 5) in approximately 50% of the patients. In comparison to Lb-stimulated cultures, lower proliferative responses of T lymphocytes to P-4 or P-8 were observed. However, the P-4- or P-8-stimulated cultures had similar percentages of reactive CD4+ and CD8+ cells, as well as type 1 cytokines (presence of IFN-gamma and IL-2, and low levels or absence of IL-4) in the supernatants both before and at the end of therapy. The consistent induction of apparently beneficial T cell responses by the P-4 and P-8 amastigote glycoproteins points to the possibility that these molecules be considered as candidates for future defined vaccines against leishmaniasis.
Similar articles
-
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?Clin Exp Immunol. 2007 Sep;149(3):440-4. doi: 10.1111/j.1365-2249.2007.03436.x. Epub 2007 Jul 5. Clin Exp Immunol. 2007. PMID: 17614975 Free PMC article.
-
Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.Cell Immunol. 2012 Oct;279(2):180-6. doi: 10.1016/j.cellimm.2012.11.006. Epub 2012 Nov 29. Cell Immunol. 2012. PMID: 23246680
-
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.Infect Immun. 2001 May;69(5):3232-9. doi: 10.1128/IAI.69.5.3232-3239.2001. Infect Immun. 2001. PMID: 11292745 Free PMC article.
-
[Immunopathology of American tegumentary leishmaniasis].Acta Cient Venez. 1998;49(1):42-56. Acta Cient Venez. 1998. PMID: 10205916 Review. Spanish.
-
T-cell response in human leishmaniasis.Immunol Lett. 1999 Jan;65(1-2):105-8. doi: 10.1016/s0165-2478(98)00132-1. Immunol Lett. 1999. PMID: 10065635 Review.
Cited by
-
Characterization of a Novel Putative S-Adenosylmethionine Decarboxylase-Like Protein from Leishmania donovani.PLoS One. 2013 Jun 19;8(6):e65912. doi: 10.1371/journal.pone.0065912. Print 2013. PLoS One. 2013. PMID: 23840377 Free PMC article.
-
Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.Clin Exp Immunol. 2011 Feb;163(2):207-14. doi: 10.1111/j.1365-2249.2010.04285.x. Epub 2010 Nov 22. Clin Exp Immunol. 2011. PMID: 21091666 Free PMC article.
-
CD8+ T cells in situ in different clinical forms of human cutaneous leishmaniasis.Rev Soc Bras Med Trop. 2013 Nov-Dec;46(6):728-34. doi: 10.1590/0037-8682-0174-2013. Rev Soc Bras Med Trop. 2013. PMID: 24474014 Free PMC article.
-
Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.Vaccine. 2007 Feb 9;25(8):1534-43. doi: 10.1016/j.vaccine.2006.10.036. Epub 2006 Nov 10. Vaccine. 2007. PMID: 17178178 Free PMC article.
-
T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.Clin Diagn Lab Immunol. 2002 Mar;9(2):251-6. doi: 10.1128/cdli.9.2.251-256.2002. Clin Diagn Lab Immunol. 2002. PMID: 11874860 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials